The human large intestine is populated by a high density of microorganisms, collectively termed the colonic microbiota 1 , which has an important role in human health and nutrition 2 . The survival of microbiota members from the dominant Gramnegative phylum Bacteroidetes depends on their ability to degrade dietary glycans that cannot be metabolized by the host To elucidate the mechanism of substrate acquisition by SusCD complexes using X-ray crystallography, we initially tried to overexpress several B. thetaiotaomicron (B. theta) SusC homologues in the outer membrane of Escherichia coli, but were unsuccessful. However, we discovered that a number of SusCD complexes are expressed at high levels (approximately 1 mg l −1 ) in B. theta (Extended Data Fig. 1 ). The notable abundance of TonB-dependent transporters (TBDTs) and the paucity of outer membrane diffusion channels such as porins in
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B. theta (Extended Data
shows that nutrients are acquired in a fundamentally different way in Bacteroidetes compared to E. coli, for example. A four-component complex produced by B. theta in minimal medium could be purified to homogeneity using ion-exchange chromatography (Extended Data Fig. 1b ) and was identified as comprising BT2261 to BT2264 (hereafter BT2261-64) by mass spectrometry. The substrate of BT2261-64 is not known, but the presence of homologues of both SusD (BT2263) and SusC (BT2264) indicates that the complex is involved in nutrient acquisition. BT2261 and BT2262 are small outer membrane lipoproteins (16 kDa and 24 kDa, respectively) that, in B. theta, are unique to the BT2261-64 system (Extended Data  Fig. 2 ). The locus coding for BT2261-64 on the B. theta genome is not in an operon with any other genes.
The structure of BT2261-64 was solved to 2.75 Å resolution using molecular replacement (Fig. 1a, c and Supplementary Tables 1-3 ; see Methods). The structure reveals that the central BT2264 (SusC) component of the complex is a typical, albeit large, TBDT (984 residues), with an N-terminal plug domain inserted into a 22-stranded β -barrel 13 ( Fig. 1d, e) . SusC forms a homodimer, burying approximately 2,900 Å 2 of surface area (Fig. 1a, c) . Identical interfaces are observed for two other crystal forms (Extended Data Fig. 3 ), suggesting the dimer is not a crystal-packing artefact. Native mass spectrometry confirms that BT2261-64 forms an octameric complex of around 400 kDa in size (Extended Data Fig. 4 ). To our knowledge, the dimeric organization of SusC is unique for TBDTs.
The SusD-like subunit BT2263 (hereafter SusD) is located on top of SusC, forming an extracellular lid on the transporter and generating a large interface area of approximately 3,800 Å 2 ( Fig. 1a, c) . The SusCSusD interaction is stabilized by around 50 hydrogen bonds and 3 salt bridges, explaining the high stability of the complex in SDS-PAGE (Extended Data Fig. 1 ). The structure of SusD bound to SusC is identical to that of SusD in isolation (Fig. 2a) , demonstrating that no conformational changes occur upon binding to SusC. The face of SusD that interacts with SusC is distant from the conserved four tetratricopeptide (TPR) repeats (Fig. 2a) , contrasting with earlier predictions 16 . Instead, the interaction surface includes the highly variable region that forms the substrate-binding site of SusD-like proteins 11, 16 ( Fig. 2c-e) . Inspection of the SusC-SusD interface reveals the presence of a well-defined, approximately 30 Å-long stretch of electron density that cannot be accounted for by anything added during bacterial growth and protein purification and crystallization. The density is modelled well by a ten-residue peptide (Fig. 3a, b and Extended Data Fig. 5 ). At a resolution of 2.75 Å, the peptide sequence is ambiguous. On the basis of relatively weak density for several side chains, we suggest that there is an ensemble of peptides bound. This would better explain why we could not identify the ligand by native mass spectrometry (Extended Data Fig. 4 ), though we cannot exclude the possibility that a unique peptide sequence is present, or even that the density might not correspond to a peptide. To account for the sequence ambiguity, we modelled the putative peptide ligand as decaglycine (Fig. 3b) . The fact that the ligand survived a large number of purification steps indicates 
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that it is tightly bound and originates from B. theta. The ligand is present in a large cavity between SusC and SusD that is not solventaccessible (Fig. 3a) and nine out of ten residues make backbone interactions with either SusC or SusD residues ( Fig. 3b and Extended Data Fig. 5) . A PISA 17 analysis reveals that the ligand interacts more extensively with SusC than SusD (540 Å 2 and 300 Å 2 of buried surface area, respectively), suggesting that the complex is a transport intermediate by which a peptide ligand has been transferred from SusD to SusC and is now tightly bound, as is typical for TBDT substrates 13 . To provide functional data for BT2261-64, we analysed expression of the complex using western blots. In contrast to known glycan uptake systems 14 , BT2261-64 is constitutively expressed during log-phase growth in minimal medium and only upregulated on rich media during the stationary phase, when cell viability drops (Fig. 3c) , suggesting that the complex is functional during conditions of nutrient stress. These expression patterns are supported by previous transcriptomic data showing the upregulation of BT2261-64 in minimal media 18 . A constructed Δ bt2264 (Δ susC) knockout strain did not give an altered phenotype under various conditions (Methods), a result that we expected given that B. theta encodes over 100 SusCD systems and the majority have unknown functions 3, 8, 14, 15 . We also did not observe binding to SusD (BT2263) by isothermal titration calorimetry (ITC) for two synthetic decapeptides that have sequences consistent with the electron density (Methods). Despite this, the overall emerging picture is that BT2261-64 imports oligopeptides derived from other members of the microbiota. Given the extremely high microbial density, bacterial turnover represents an underappreciated but potentially important source of nutrients in the gut. It is also possible that BT2261-64 serves as a receptor for signalling peptides (for example, in quorum sensing) 19 . The ligand-binding site in the complex is excluded from solvent ( Fig. 3a) , indicating that SusD must dissociate from SusC to capture substrate from the external environment. To determine how the substrate is delivered by SusD to the transporter we performed unbiased molecular dynamics simulations on the central hub BT2263-BT2264 (SusC-SusD; a dimer) and on BT2261-64 (tetramer and octamer) in the presence and absence of a modelled peptide (the holo-and apo-complex, respectively; Methods). In holo-complex simulations, all complexes are stable for the duration of the simulations (Fig. 4a-c , Extended Data Fig. 6 and Supplementary Videos 1-3) . Although it remains at the SusC-SusD interface, the conformation of the peptide varies substantially and non-uniformly in all simulations (Fig. 4a , Extended Data Fig. 7 and Supplementary Videos 1-3) . The peptide movement in the simulations appears hard to reconcile with the presence of well-defined electron density in the crystal structure. The most likely explanation for this discrepancy is that the peptide sequence used in the simulations is not stable in the binding site. Together with the peptide ITC data, this suggests that the BT2261-64 system is, at least to some extent, sequence-specific. Despite the movement of the peptide, the total number of hydrogen bonds with SusC and SusD remains approximately constant (Extended Data Fig. 6 ).
In the majority of apo-complex simulations, SusD undergoes a hinge-like motion to expose the ligand-binding site to the external environment. The extent of opening between different simulations varies owing to thermal fluctuations, but in the most open states, SusD rotates around 40-45° and completely loses its contacts with loops L1, L3-5, and L9-L11 of SusC ( Fig. 4b and Supplementary Videos 1-3). Analysed in a different way, the C α -C α distance between residues at the front of the complex (Thr296 in SusD and Asn203 in SusC) increases from approximately 6 Å in the closed, ligand-bound complexes to approximately 40 Å in open, ligand-free states (Fig. 4c) . The conformational changes are very similar in all simulations in which lid-opening is observed and correspond to a rigid-body movement of SusD (Extended Data Fig. 8 ). Loop L7 of SusC moves together with SusD and is responsible for the majority of the remaining SusC-SusD interactions in the open state. We term L7 the hinge loop, and it is the region in SusC that exhibits the greatest conformational differences between the holo-and apo-complex simulations (Extended Data Fig. 8 ).
The hinge point at the base of L7 is located at the back of the complex, near the SusD lipid anchor (Fig. 4b) . The octamer simulation demonstrates that SusC dimerization does not impede opening of the SusD lid and, moreover, suggests that both SusCD hubs function independently (Fig. 4c , Extended Data Fig. 9 and Supplementary Video 3). A final implication of the computational results is that because removal of the ligand produces a mechanistically sensible response (that is, SusD lid-opening), the molecular dynamics simulations support our modelling of the BT2261-64 ligand as an oligopeptide. Even if the ligand is not a peptide, its location at the SusC-SusD interface would stabilize the closed state of the complex; that is, the results of the molecular LETTER RESEARCH dynamics simulations of the holo-complex would probably not depend on the assigned identity of the ligand. This notion is supported by the fact that the SusD lid remains closed, despite the fact that the peptide assumes many different conformations during the simulations.
The large number and sequence diversity of SusCD gene pairs in Bacteroidetes and especially Bacteroides spp. 3, 8, 14, 15 led us to investigate whether the BT2261-64 structure and transport mechanism are representative of other SusCD complexes. To address this issue, we determined the crystal structure of BT1762-BT1763, which is part of a seven-gene polysaccharide utilization locus (PUL) with an established function in levan (β 2,6-fructan) degradation 4 . No other proteins copurify with BT1762-BT1763 (Extended Data Fig. 1d) , suggesting that the accessory PUL outer membrane lipoproteins are not an integral part of this complex. Native mass spectrometry and size-exclusion chromatography-multi-angle light scattering (SEC-MALS) show that BT1763 (SusC) also forms homodimers (Extended Data Fig. 4) . The crystal structures confirm this and show that the relative orientations of BT1762 (SusD) and BT1763 are the same as in the BT2263-BT2264 complex, with SusD capping SusC (Figs 1b and 2b) . As is the case for BT2263-BT2264, binding to SusC does not cause significant conformational changes in SusD (Fig. 2b) . Notably, the hinge loop (L7) observed in BT2264 is also present in BT1763 (Fig. 1f) . No substrate is bound in the BT1762-BT1763 structure, in accordance with the known high specificity of the complex 4 and the fact that no substrate was added during cell growth. The reason that the SusD lid is closed is probably related to the fact that crystallization favours stable, compact states. Unexpectedly, no density is observed for the plug domain of BT1763 (Fig. 1f) and SDS-PAGE indicates that BT1763 has a molecular weight approximately 20 kDa lower than BT2264 from crystal-containing drops (Fig. 4e) . Removal of the plug and the preceding DUF4480 domain also occurs after prolonged incubation of freshly isolated complex, presumably through proteolytic cleavage by a co-purified contaminant (Fig. 4e) . We took advantage of these different BT1762-BT1763 complexes to obtain experimental evidence for opening of the SusD lid by single-channel electrophysiology. Reconstitution of freshly purified, full-length SusC-SusD complex in the planar lipid bilayer generates very small and relatively stable ion currents, consistent with the absence of a large channel in intact TBDTs. By contrast, the plug-less complex (SusCD Δplug ) produces large channels with average conductance values of around 1.5 nS. The amount of noise in the traces is very high and a wide range of conductance values are observed (including 0 nS), indicating dynamic opening and closing events (Fig. 4d) . To exclude the possibility that gating by extracellular SusC loops was responsible for the observed dynamics in the plug-less BT1762-BT1763 complex, we isolated truncated BT1763 from SDS-PAGE gels, followed by refolding and reconstitution (SusC Δplug ). This produces large channels with similar conductance values (around 3 nS) as measured for a genetically created plug-less FhuA TBDT 20 .
In contrast to those of SusCD
Δplug , the plug-less SusC channels are stable, indicating that the extracellular loops of SusC are not responsible for the dynamics observed in SusCD Δplug (Fig. 4d) . Lastly, full-length SusC (SusC with plug) behaves similarly to full-length SusCD and does not form channels, demonstrating that refolding and reconstitution generates correctly folded transporters. The electrophysiology data for the levan importer therefore provide experimental evidence that fully supports the dynamic opening and closing of the SusD lid in ligand-free complexes observed by molecular dynamics simulations of the putative peptide importer.
To provide functional support for the structures and transport mechanism, we focused on BT1762-BT1763, because robust growth of B. theta on levan is dependent on an intact copy of BT1762 (ref. 4) . We predicted the aromatic residues Trp85, Trp286, Tyr395 and Trp396 as well as the disulfide-bonded residues Cys298 and Cys299 to be in or close to the putative levan-binding site on BT1762 (SusD) on the basis of sequence alignment and comparison with the ligandbound structures of the archetypal SusD (BT3071; Fig. 2 ) and BT1043 (Protein Data Bank (PDB) accession number: 3EHN) 21 . Individual alanine mutants were produced in E. coli and levan binding to purified BT1762 variants was assessed by ITC. Mutation of Trp85 and Cys298 resulted in complete loss of levan binding, whereas the Tyr395 mutant displayed around sixfold loss of affinity (Extended Data Fig.  10 ). Mutation of other aromatic residues, including ones far away from the binding site had no effect (for example, Tyr280 or Trp479). The locations of the residues that abolish levan binding to SusD are in agreement with the positioning of SusD within the SusCD complex and also with the location of the ligand-binding site in BT2261-64 (Fig. 3d) .
Combining our structural and functional data and previous mechanistic insights for TBDTs 13 we propose a 'pedal bin' mechanism for nutrient acquisition by SusCD-like systems (Fig. 4f) . In the absence of substrate, the SusD lid of the empty transporter is mobile and samples a range of conformational states. Upon substrate binding, the closed state represented by the crystal structures is stabilized by ligand interactions with both SusC and SusD (Fig. 3b) . The final step in transport involves the binding of TonB to the TonB box of the transporter 22, 23 to generate the conformational changes in the plug and, potentially, the extracellular loops of SusC that lead to substrate release and the formation of a transport channel into the periplasmic space 13 . The TonB box of BT2264 (residues 23-29) is not visible in the structures, consistent with the view that this segment is mobile and accessible in ligand-bound TBDTs to allow binding and recognition by TonB 13 . Residue Leu120 of the plug loop in BT2264 contacts the peptide through van der Waals interactions (Fig. 3b) , providing a direct link between the ligand and the SusC plug and a potential way to signal to TonB that the binding site in BT2264 is occupied 13 . The TonB-induced dissociation of the substrate reverts the transporter back to the dynamic open state; the energy input from the ExbBD-TonB 24, 25 system is therefore equivalent to pressing the pedal to open the SusCD bin (Fig. 4f) . The proposed transport mechanism also provides a rationale for the essential requirement of a surface-located endo-acting enzyme in many PULs [4] [5] [6] 10 , as formation of the closed 'transport competent' complex appears to involve envelopment of the whole ligand molecule (Fig. 3a) , precluding the import of undigested glycans with high molecular weights.
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No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Purification of native BT2261-64 complex. Wild-type B. theta was grown on minimal media containing fructose (0.5% w/v) as a carbon source at 37 °C under anaerobic conditions overnight. At A 600 of 1.5-2.0, cells were collected by centrifugation at 11,305g for 30 min. Cells were resuspended in TSB buffer (20 mM Tris, 300 mM NaCl; pH 8) and lysed at a pressure of 23 kpsi using a cell disrupter (Constant Systems 0.75 kW). The cells were centrifuged at 205,000g for 1 h to collect total membranes. The pellets were resuspended and homogenized in 20 mM HEPES (pH 7.5) containing 0.5% (w/v) sodium lauroyl sarcosine. Typically, 100 ml buffer was used for 2 l of cells. The sample was incubated while stirring at 20 °C for 30 min and centrifuged at 205,000g for 30 min. The supernatant was discarded and the process was repeated. The clear, translucent pellets containing the outer membrane proteins were resuspended and homogenized in 1.5% (w/v) lauryldimethylamine-N-oxide (LDAO) buffer (10 mM HEPES, 50 mM NaCl; pH 7.5) and incubated while stirring at 4 °C overnight. The sample was centrifuged at 205,000g for 45 min and the supernatant containing outer membrane proteins was collected. The sample was passed through a 0.45-μ m filter, loaded on a 6-ml Resource Q anion-exchange column and eluted with a linear gradient of NaCl (Extended Data Fig. 1 ). The BT2261-2264 peak was collected and further purified by gel filtration chromatography in 10 mM HEPES, 100 mM NaCl, 0.12% n-decyl-β -d-maltoside (pH 7.5) using a HiLoad 16/60 Superdex 200 column. Peak fractions were pooled and the buffer was exchanged to 10 mM HEPES, 100 mM NaCl, 0.4% tetraethylene glycol monooctyl ether (C 8 E 4 ) (pH 7.5) using a 100 kDa MWCO ultrafiltration device (Millipore). The protein was concentrated to 7-10 mg ml ). The cells were incubated for a further 17 h to a final A 600 of approximately 1.7 and collected. Bacteria were processed and BT2261-64 was purified as described above. Purification of BT1762-BT1763 complex. A 4× Ala linker and 6× His-tag were added to the C terminus of genomic bt1762 (susD) using pExchange-tdk 11 . The mutated B. theta cells were grown on minimal media with 0.5% fructose under anaerobic conditions as fructose is known to activate expression of the levan PUL (bt1757-bt1763) (ref. 4) . Cells were collected and processed as outlined above. Following solubilisation with LDAO, the His-tagged complex was purified by cobalt-affinity chromatography (Talon) followed by gel filtration with a HiLoad 16/60 Superdex 200 column in 10 mM HEPES, 100 mM NaCl, 0.12% DM (pH 7.5). For crystallization the detergent was exchanged to C 8 E 4 by a second gel filtration step in 10 mM HEPES, 100 mM NaCl, 0.4% C 8 E 4 (pH 7.5). Overexpression and purification of BT2262 and BT2263. The mature parts of bt2262 and bt2263 lacking the N-terminal cysteine were amplified using PCR for ligation independent cloning into a pET9 vector containing a kanamycin resistance gene for selection, a PelB signal sequence for targeting proteins to the periplasm and a N-terminal TEV protease-cleavable 10× His-tag. After TEV cleavage, the sequence 'SM' is added to the first residue of the cloned sequence. The vector was digested using BsaI and annealed with the insert using T4 DNA polymerase. Proteins were expressed in BL21 (DE3) E. coli cells grown in LB media at 37 °C to A 600 of approximately 0.6 and induced with 0.2 mM IPTG then incubated at 18 °C overnight. Cells were collected at 2,826g for 30 min, resuspended in TSB buffer and lysed at 23 kpsi using a cell disrupter. The lysed cells were centrifuged at 205,000g for 45 min and the supernatant was collected. The proteins were purified using nickel-affinity chromatography (Chelating Sepharose; GE Healthcare) and eluted with TSB buffer containing 250 mM imidazole. The buffer was exchanged with TEV cleavage buffer (50 mM Tris, 50 mM NaCl, 0.5 mM EDTA, 0.5 mM TCEP; pH 8). TEV protease was added at a ratio of approximately 5-10:1 (w/w) (protein:TEV) and the His-tag was cleaved overnight at room temperature with gentle rocking. The cleaved proteins were subjected to a second round of nickel affinity chromatography. Tag-less proteins were further purified by gel filtration in 10 mM HEPES, 100 mM NaCl pH 7.5 using a HiLoad 16/60 Superdex 200 column, and concentrated to approximately 10-15 mg ml −1 for crystallization. Crystallization of BT2262 and BT2263. Sitting drop crystallization trials were set up using a Mosquito crystallization robot (TTP Labtech) using commercial screens (Molecular Dimensions Structure, Index, PACT and JCSG+ screens). Initial hits were obtained in Structure, #37 for BT2263 (0.2 M sodium acetate trihydrate, 0.1 M Tris (pH 8.5), 30% (w/v) PEG4000) and Structure, #30 for BT2262 (2 M ammonium sulphate, 0.1 M HEPES (pH 7.5), 2% (w/v) PEG400). Crystallization and structure determination of BT1762. The mature part of BT1762 was overexpressed in the cytoplasmic space of E. coli BL21(DE3) and purified by cobalt affinity chromatography. The protein was crystallized using the sitting drop method using a Mosquito robot (TTP Labtech). Rod-like crystals grew in 2.0 M ammonium sulphate, 100 mM sodium acetate (pH 4.6) and 8% PEG 4000. Both native and SeMet data were collected on beamline I03 at the Diamond light source, Didcot, UK. Data were processed and integrated to 1.8 Å with XDS 27 and scaled with Aimless 28, 29 . Space group determination was tested with Pointless 29 . The phase problem was solved by SeMet single-wavelength anomalous dispersion (SAD) using HKL2MAP 30 and Shelx C/D/E pipeline 31 . An initial model was produced by Buccaneer 32 using the SAD data and used as a search model for molecular replacement using Molrep 33 on the native data. The model was completed using iterative cycles of refinement with Refmac5 (ref. 34) and manual model-building using COOT 35 . The R free set of reflections was 5% of the unique reflections, randomly selected. The model was validated using Molprobity 36 .
Crystallization and structure determination of BT2261-64. Sitting-drop crystallization trials were set up using a Mosquito crystallization robot (TTP Labtech) using commercial screens (Molecular Dimensions MemGold 1 and 2) and in-house screens. The triclinic and orthorhombic crystals for native BT2261-64 as well as the crystals for SeMet-substituted complex were produced by the same condition (MemGold 2 #44; 0.2 M magnesium formate dihydrate, 0.05 M Tris (pH 8), 18-22% (w/v) PEG 3350), although the triclinic crystals occurred very infrequently. Diffraction data were collected at 100 K at the Diamond Light Source, on beamlines I03 (BT2263), I04 (BT2261-64 and BT1762-1763) and I24 (BT2261-64). All diffraction data were processed with XDS and Pointless was used for space group determination. Data were scaled using Aimless.
After obtaining well-diffracting crystals for native BT2261-64, we performed molecular replacement trials in Phaser 37 with both crystal forms, using components available within the PDB at that time. These consisted of FepA 38 (PDB ID: 1FEP; 14% identity to BT2264), BT2259 (PDB ID: 4Q69; 26% identity to BT2263) and BT2261 (PDB ID: 3H3I). However, none of these trials produced a plausible solution, including searches that were performed with Sculptor-modified 39 search models. We then obtained crystals of soluble BT2263 and solved its structure using molecular replacement using BT2259 as a search model (26% sequence identity). Subsequently a definite molecular replacement solution for the complex was found by Phaser for a P1 crystal using BT2263 and Sculptor-modified FepA as search models (RFZ = 14.7, TFZ = * , PAK = 0, LLG = 503, RFZ = 10.4, TFZ = 29.9, PAK = 0, LLG = 1195, RFZ = 5.5, TFZ = 10.3, PAK = 3, LLG = 1263, RFZ = 5.7, TFZ = 9.0, PAK = 7, LLG = 1220, LLG = 1789; 2 copies each of BT2263 and BT2264). RFZ, rotation function Z-score; TFZ, translation function Z-score; PAK, number of clashes from packing analysis; LLG, log likelihood gain. Subsequent auto-building within Phenix 39 yielded a model with R free of approximately 44%. Placement of two copies of BT2261 using molecular replacement was straightforward at this stage. Subsequent rounds of manual building of BT2264 and the N-terminal domain of BT2262 within COOT 35 depended critically on using density-modified maps produced by RESOLVE 40 , in particular after application of two-fold non-crystallographic symmetry (NCS). During the later stages of model building and Phenix refinement, we solved the structure of BT2262 by molecular replacement using the N-terminal domain (residues 4-110) from the complex as a search model. When the R free of the model for the complex reached around 28%, BT2262 was placed in the density, guided by its N-terminal domain. Refinement of B-factors was done isotropically including TLS, with each protein chain taken as a separate group. NCS was not used. For all structures, protein geometry was validated with MolProbity 36 . Figures were produced with PyMOL 41 (Schrödinger LLC). In the final model of BT2261-64, only one copy of BT2262 is visible within the complex (residues 4-212; numbering from the first residue of the mature sequences), with poor density for the C-terminal domain. Besides BT2262, the final model contains two copies of BT2264 (residues 37-984), two copies of BT2263 (residues 1-480) and two copies of BT2261 (residues 3-148). Of the two complexes in the asymmetric unit, the best density is observed for the complex consisting of chains ABFG, and the electron density maps for the peptide reported here were based on this complex. For the other complex in the P1 asymmetric unit (chains CDE) as well as for some of the complexes in the other space groups, the peptide density is slightly different. It is not clear at this point whether the differences in density for the peptide are a consequence of the possible presence of a bound ensemble.
During the later stages of structure refinement of BT2261-64 we also obtained diffracting crystals for SeMet-substituted complex in space group P2 1 . Both SAD and MAD datasets were collected for these crystals but none of these provided phases of sufficient quality to solve the structure de novo. Given that the anomalous LETTER RESEARCH signal was weak, the failure of phasing was most likely due to a low level of SeMet incorporation by B. theta. However, anomalous difference maps could be produced that provided a useful independent registry check using the 51 methionine residues present in the tetrameric BT2261-64 complex.
The structures of the BT2261-64 complex in space groups P2 1 2 1 2 1 and P2 1 were solved by molecular replacement in Phaser using the individual components from the P1 crystals as search models, and refined with Phenix. The orthorhombic complex contains 2 molecules of each of the subunits, with the C-terminal domains of both BT2262 subunits missing. In the monoclinic, SeMet complex, no density is visible for either of the BT2262 subunits, confirming the dynamic nature of this subunit (Extended Data Fig. 3) . Extended Data Fig. 3 also shows that the triclinic structure has the lowest B-factors and consequently yielded the best-quality maps. The data collection and refinement statistics are summarized in Supplementary  Tables 1 (BT2261-64) 2 1 2), using the BT1762 structure and a Sculptor-generated model of BT2264 (21% sequence identity) as search models. In this crystal, there is only one SusC protomer within the asymmetric unit, with the SusC homodimer generated by crystallographic symmetry. Autobuilding within Phenix resulted in a model with R free ≈ 43-44% (R ~ 39%), comparable to BT2261-64 at a similar stage of refinement. Due to the lack of non-crystallographic symmetry (NCS) the maps were of insufficient quality to build a more complete model for BT1763. We then obtained another crystal form (crystal form 2; P2 1 Following Autobuilding within Phenix, a model was built using iterative cycles of manual building and refinement within Phenix. During later stages of refinement, NCS was omitted and TLS refinement of B-factors was applied (one domain per chain). The structure of crystal form 1 was then solved by molecular replacement, followed by refinement in Phenix as described above. The data collection and refinement statistics for BT1762-BT1763 are summarized in Supplementary Table 3 . Knockout construction of BT2264 and growth experiments. Two rounds of PCR were used to create a product with the desired sequence, including 1,000 bp upstream and downstream of the knockout region. This was ligated with pExchange-tdk vector 11 which was then used for genetic recombination. The BT2264 knockout and wild-type strains were grown on TYG rich media and minimal media containing 0.5% fructose or glucose. In addition, growth on MM-Fructose plus tryptone (1%) was tested. The cells were incubated for 72 h at 37 °C under anaerobic conditions and the A 600 was taken every 15 min using a plate reader. The BT2264 knockout strain showed no altered growth phenotype under any of the conditions tested. Western blot analysis. pExchange-tdk 11 was used to add a 4× Ala linker and Flag-tag (DYDDDDK) to the C terminus of BT2263 (SusD) in wild-type B. theta. The resulting mutant strain was grown in TYG rich media and minimal media containing 0.5% fructose, and samples were collected over 24 h. The whole cells were diluted to relative colony forming units using Bugbuster detergent and solubilised. The solubilised material was analysed by western blot using Sigma F7425 Anti-Flag (1 in 2,000 dilution) as the primary antibody and goat anti-rabbit IgG-HRP: sc-2004, Santa Cruz Biotechnology (1 in 5,000 dilution) as the secondary antibody. ITC of BT1762. Site directed mutagenesis of the mature form of BT1762 cloned into pRSETA (Invitrogen) was performed using the Quikchange kit (Agilent) according to the manufacturers protocol. The affinity of wild type and mutants (numbered from the mature form of the protein) for levan was quantified by isothermal titration calorimetry (ITC) using a Microcal VP-ITC. In brief, the protein sample (50-60 μ M), stirred at 300 r.p.m. in a 1.4-ml reaction cell, was injected with 27-29 aliquots of 10 μ l levan (0.5-2% w/v). Titrations were carried out in 20 mM Na-HEPES buffer, pH 7.5 at 25 °C. Integrated binding heats, minus dilution heat controls, were fit to a single set of sites binding model to derive K a using Microcal Origin v7.0. At least two independent titrations were performed for each protein tested. The molar concentration of binding sites present in levan was determined by altering the concentration of ligand used for regression of the isotherm until the fit yielded a value of 1 for n (number of binding sites on each molecule of protein) for the wild-type and using this value for all titrations. The assumption that n = 1 was deemed valid based on the structure and mutant binding data. ITC of BT2263. We probed the possible interaction between two synthetic oligopeptides (Biomatik Corporation) and SusD-like BT2263. The first peptide was a hypothetical, negatively charged sequence consistent with the density (GSSGGQQEGG), whereas the second contained several positively charged residues (GDSGSKQKKG), again based on a possible assignment. In addition, the binding to poly-dl-alanine (Sigma P9003; MW, 1,000-5,000 Da) was investigated. Peptides at 10 mM in buffer were titrated to 40 μ M BT2263 as described above. Native mass spectrometry. The protein sample was buffer exchanged to 1 M ammonium acetate containing 0.5% C 8 E 4 using a biospin 6 column (Bio-Rad). Typically, 2-3 μ l of the protein samples were loaded onto a gold-coated borosilicate capillary (outer diameter, 1 mm). Proteins were transmitted into a Synapt HDMS mass spectrometer (Waters) modified to facilitate the transmission of high mass species using a nano-ESI apparatus. Instrument parameters were set as follows: backing pressure, 6 mBar; capillary voltage, 1.6 kV; cone voltage, 170 V; trap and transfer collision energy were 200 V for the BT2261-64 complex and 100 V for BT1762-BT1763. Data analysis was carried out using Masslynx 4.1 (Waters). SEC-MALS. SEC-MALS was performed using an ÄKTA Pure with Superdex 200 10/300 GL Increase (GE Healthcare), with in-line DAWN HELIOS II MALS detector (eight fixed angles) and Optilab T-rEX differential refractometer (Wyatt Technology). BT1762-BT1763 (100 μ l of 7 mg ml −1 ) was analysed in 10 mM HEPES (pH 7.5), 150 mM NaCl, 0.05% dodecyl-β -d-maltoside. Data were collected and analysed using ASTRA 6 (Wyatt Technology). Molecular weights for the protein-detergent complex and its protein and detergent constituents were determined through protein-conjugate analysis with Zimm plot extrapolation using dn/dc values of 0.1850 ml g −1 and 0.1435 ml g −1 for protein and detergent respectively, and a protein UV extinction coefficient of 1.86 ml mg
Refolding of Sus proteins from SDS-PAGE.
The proteins were refolded from gels using a simple refolding protocol. In brief, the samples were mixed with loading buffer (final concentrations: 75 mM Tris (pH 6.8), 15% glycerol, 0.6% SDS, 5% β -Mercaptoethanol, 0.01 mg ml −1 bromophenol blue) and heated for 15 min at 90 °C. Each sample was loaded onto multiple wells for a higher yield on a 12% SDS gel along with the PageRuler Prestained Protein ladder (Thermo Scientific, Product no. 26617). Part of the gel was silver stained. Thin slices of the unstained gel were excised along the expected size of the band by comparing with its stained counterpart and were transferred to a vial containing 1% Genapol. Gel pieces were crushed gently for about half an hour using a micro pestle to make the solution homogenous. The suspension was kept for overnight incubation at 8 °C with 550 r.p.m. shaking on a Thermomixer. Following overnight incubation, the mixture was centrifuged at 3500g for 30 min and the supernatant was collected and checked for channel activity by electrophysiology. Single-channel electrophysiology. Electrophysiology measurements were carried out using a single channel reconstitution protocol as described elsewhere 42 . In short, a teflon cuvette was used in which a 25-μ m thick Teflon film with an aperture size of around 50-100 μ m was inserted between the two chambers. 1-2 μ l of a solution containing 1% hexadecane in hexane was used to impregnate the area around the aperture to make it more hydrophobic (lipophilic) and left to dry. The two chambers were filled with 1 M KCl and 10 mM HEPES (pH 7). Around 2 μ l solution of 5 mg DPhPC (diphytanoylphosphatidylcholine, Avanti polar lipids) dissolved in 1 ml n-pentane was used to form the membrane using the Montal and Muller technique 43 . A pair of Ag/AgCl electrodes (World Precision Instruments) was used to measure the ionic current across the membrane where one of the electrodes is connected to the cis (ground) side of the membrane and the other was connected to the trans headstage of the Axopatch 200B amplifier (Axon Instruments). Protein dissolved in 1% Genapol was always added to the cis side of the membrane. The ion current trace was filtered using a low pass Bessel filter at 10 kHz and was recorded using a sampling frequency of 50 kHz. Data were analysed using the Clampfit program. The data thus obtained were filtered at 5 kHz for obtaining a clear view of the traces. The data shown in Fig. 4d were obtained at + 50 mV. Molecular dynamics simulations. Molecular dynamics simulations were carried out with GROMACS 4.6.5 (ref. 44 ) using the all atom CHARMM36 force field for protein, lipids and ions 45, 46 using standard procedures for membrane proteins 47 . Long-range Coulomb interactions were calculated using the partice-mesh Ewald (PME) summation method with a short-range cut-off of 1.2 nm and a Fourier grid spacing of 0.12 nm. At the same time, Lennard-Jones interactions were considered up to a distance of 1 nm, and a switch function was used to smoothly switch off the interactions to reach zero at 1.2 nm. The unbiased simulations were performed under constant pressure (1 bar) and constant temperature (300 K) with a time
